Synagistics Limited — Board/Management Information 2016

Jun 27, 2016

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [156 x 58] intentionally omitted <==

OP FINANCIAL INVESTMENTS LIMITED 東英金融投資有限公司 *****

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1140)

RE-DESIGNATION OF DIRECTOR AND

APPOINTMENT OF ADDITIONAL MEMBER OF CORPORATE GOVERNANCE COMMITTEE

The board (the “Board” ) of directors (the “Directors” ) of OP Financial Investments Limited (the “Company” ) is pleased to announce that Dr. Liu Zhiwei ( “Dr. Liu” ), will be re-designated from the position of non-executive Director to executive Director and will be appointed as the president of the Company with effect from 28 June 2016. He will be further appointed as an additional member of Corporate Governance Committee of the Company on the same day.

Dr. Liu, aged 48, obtained a bachelor’s degree in Industrial Management Engineering from Zhe Jiang University in 1989. He furthered his studies in Graduate School of the People’s Bank of China between 1989 and 1992 and obtained his master’s degree in international finance. In 2007, he obtained a doctoral degree in Economics & Law from Hunan University. Dr. Liu completed a professional programme in Finance CEO from Cheung Kong Graduate School of Business in 2010.

Dr. Liu has over 20 years of experience in financing, securities investment and capital market. He is an entrepreneur and is currently the chairman of each of Shanghai Chunda Asset Management Co., Ltd and Bestone Asset Management Company Limited. Dr. Liu served as a non-executive director of Shanghai Zendai Property Limited (stock code: 755), whose shares are listed on The Stock Exchange of Hong Kong Limited ( “Stock Exchange” ) for the period from 2 February 2010 to 12 December 2012. He was the vice-chairman of Xi’an International Trust Co., Ltd from 2008 to 2011. Dr. Liu served as a supervisor of Xin Jiang Hui-tong (Group) Co., Ltd (stock code: 415) from December 2005 to December 2008, whose shares are listed on the Shenzhen Stock Exchange. He also served as a general manager of the merger and acquisition department of Guosen Securities Co., Ltd from 1997 to 1998.

* For identification purpose only

1

Save as disclosed above, Dr. Liu (i) does not have any relationship with any Director, senior management, substantial or controlling shareholder (having the meaning ascribed to it in the Rules Governing the Listing of Securities on the Stock Exchange ( “Listing Rules” )) of the Company; (ii) does not hold any other positions with the Company or its subsidiaries; and (iii) did not hold any directorship in the three years immediately preceding the date of this announcement in public companies, the securities of which are listed on any securities market in Hong Kong or overseas.

As at the date of this announcement, Dr. Liu has personal interests of 182,056,000 ordinary shares of the Company (representing approximately 9.89% of the entire issued share capital).

Upon Dr. Liu’s re-designation as executive Director, his existing letter of appointment with the Company was terminated and a new letter of appointment will be entered into between Dr. Liu and the Company for his capacity as an executive Director for a term of three years effective from 1 December 2015. He will be subject to retirement by rotation and re-election at the next annual general meeting in accordance with the Articles of Association of the Company. Dr. Liu is entitled to a director’s fee of HK$250,000 per annum, which was determined and approved by the Remuneration Committee of the Company on the basis of his level of responsibility and by reference to his experience and the prevailing market benchmark.

Other than the above, the Board is not aware of any other matters in relation to the re-designation of Dr. Liu that need to be brought to the attention of the shareholders of the Company or any information that should be disclosed pursuant to any of the requirements of Chapter 13.51(2)(h) to 13.51(2)(v) of the Listing Rules.

By order of the Board OP Financial Investments Limited Zhang Gaobo Executive Director & CEO

Hong Kong, 27 June 2016

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Zhang Zhi Ping, Mr. Zhang Gaobo; one non-executive Director, namely Dr. Liu Zhiwei; and three independent non-executive Directors, namely, Mr. Kwong Che Keung, Gordon, Professor He Jia and Mr. Wang Xiaojun.

2